Laboratory Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

Equipment is the fastest growing sector, North America is the largest market

The Global Laboratory Supplies Market is projected to expand significantly, from USD 42.12 Billion in 2025 to USD 63.18 Billion by 2031, demonstrating a Compound Annual Growth Rate (CAGR) of 6.99%. This market encompasses a broad spectrum of consumables, reagents, and instruments essential for scientific research, clinical diagnostics, and industrial quality control.

Growth is largely propelled by increased research and development (R&D) investments in the pharmaceutical and biotechnology industries, which demand a steady supply of high-quality experimental materials. Concurrently, the rising incidence of chronic diseases fuels diagnostic testing volumes, and stringent regulatory requirements for product safety mandate robust analytical procedures across various industries. Notably, in 2024, the EU27 chemical industry's research and innovation spending reached €10.4 billion, according to the European Chemical Industry Council, highlighting the substantial financial commitment that sustains the demand for these vital laboratory resources.

Despite this growth, the market faces a substantial challenge due to the considerable acquisition and upkeep costs associated with sophisticated analytical equipment. This financial strain can critically impact the operational budgets of smaller research institutions and academic facilities, impeding their capacity to acquire essential technologies. Furthermore, fluctuations within the supply chain frequently intensify these cost pressures, leading to delays and unpredictable pricing for vital consumables. These economic limitations have the potential to impede the adoption of high-end laboratory solutions and temper the market's overall expansion pace.

Market Drivers

The primary driving force behind the Global Laboratory Supplies Market is the increasing investment in research and development within the pharmaceutical and biotechnology industries. As companies intensify their efforts to innovate new therapeutics, especially in areas like oncology and immunology, the demand for premium reagents, chromatography columns, and plastic consumables has surged.

A clear example of this trend is Johnson & Johnson's allocation of $17.2 billion towards R&D, as reported in their '2024 Investor Fact Sheet' in April 2025, demonstrating the significant capital expenditure propelling this demand. Such corporate spending directly contributes to consistent revenue growth for major equipment suppliers, who provide the essential infrastructure for drug discovery. For instance, Thermo Fisher Scientific reported a quarterly revenue increase to $11.12 billion, largely attributed to strong operational performance and demand for scientific instruments, as detailed by Investing.com in October 2025.

Concurrently, a substantial rise in government funding and grants for life sciences is significantly boosting market expansion, particularly benefiting academic and non-profit research institutions. Public financing is crucial for fundamental scientific research, which depends heavily on a consistent flow of both general laboratory supplies and advanced instrumentation. The National Institutes of Health (NIH) received a total program funding of $46.995 billion for fiscal year 2025, as stated in the Congress.gov report 'National Institutes of Health (NIH) Funding: FY1996-FY2026 Request' from December 2025. This substantial funding allows universities and federal laboratories to upgrade their facilities and acquire necessary consumables, thereby stabilizing supply chain demand against the inherent fluctuations of private sector investments and ensuring continuous market growth across diagnostic and biomedical sectors.

Market Challenges

The global laboratory supplies market faces a significant hurdle due to the substantial acquisition and ongoing maintenance costs of advanced analytical equipment. State-of-the-art instruments, including mass spectrometers and automated sequencing platforms, require considerable initial capital outlays that are often unaffordable for smaller research organizations, independent diagnostic laboratories, and academic facilities. This financial obstacle restricts the overall market size, compelling budget-limited entities to postpone purchases or prolong the use of outdated machinery instead of investing in modern, more efficient technologies. As a result, the adoption rate of new equipment slows, directly diminishing the subsequent demand for compatible consumables and reagents, which constitute a significant part of the market's recurring revenue.

Moreover, uncertainties within the supply chain aggravate these financial difficulties by causing unpredictable price shifts for essential components, further stretching operational budgets. When a large proportion of available funds must be allocated to acquiring and maintaining hardware, less capital is available for expanding experimental capabilities. The European Federation of Pharmaceutical Industries and Associations reported that in 2024, the research-based pharmaceutical industry in Europe invested approximately €55 billion in R&D. While this considerable expenditure illustrates the sector's vast scale, it also highlights the immense financial requirements for sustained operations, thereby centralizing market activity among major, well-funded companies and creating a difficult competitive and growth environment for smaller participants.

Market Trends

Procurement strategies are being fundamentally transformed by the adoption of Green Lab Certification programs and sustainable packaging, as institutions aim to reduce carbon emissions throughout their supply chains. Laboratories are increasingly favoring suppliers that provide validated low-carbon consumables and circular economy solutions, seeking to lessen the environmental footprint of plastic waste and chemical disposal. This strategic shift is underscored by the industry's growing adherence to strict environmental standards, aligning with corporate climate objectives. As noted by My Green Lab in its 'Carbon Impact of Biotech and Pharma Report' in November 2024, 31% of companies with robust emissions data have officially established medium-term Scope 1 and 2 targets consistent with the 1.5°C pathway, indicating a significant, compliance-driven move towards purchasing certified sustainable products.

Concurrently, the market is observing a rapid transition to single-use technologies (SUT) in bioprocessing, a trend driven by the demand for enhanced flexibility and reduced risks of cross-contamination in drug manufacturing. In contrast to conventional stainless-steel systems, SUTs eliminate the need for time-intensive cleaning validations and enable swift facility changeovers, which is crucial for the production of intricate cell and gene therapies. This operational evolution is clearly reflected in the substantial revenues generated by providers specializing in these technologies. Sartorius's Bioprocess Solutions Division, which predominantly offers single-use solutions for biopharmaceutical manufacturing, reported sales revenue of €2.69 billion in its 'Annual Report 2024' (February 2025), highlighting the industry's continued reliance on disposable processing infrastructure.

Key Market Players

• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Bruker Corporation
• Danaher Corporation
• FUJIFILM Holdings Corporation
• PerkinElmer Inc.
• Sartorius AG
• Shimadzu Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation

Report Scope

In this report, the Global Laboratory Supplies Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Laboratory Supplies Market, by Product:

• Equipment
• Disposables

Laboratory Supplies Market, by Region:

• North America
• Europe
• Asia Pacific
• South America
• Middle East & Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Laboratory Supplies Market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

This product will be delivered within 1-3 business days.